| Literature DB >> 29497409 |
Sandra S Scholz1, Wolfgang Schmidt-Heck2, Reinhard Guthke2, Alexandra C U Furch1, Michael Reichelt3, Jonathan Gershenzon3, Ralf Oelmüller1.
Abstract
Verticillium dahliae is a soil-borne vascular pathogen that causes severe wilt symptoms in a wide range of plants. Co-culture of the fungus with Arabidopsis roots for 24 h induces many changes in the gene expression profiles of both partners, even before defense-related phytohormone levels are induced in the plant. Both partners reprogram sugar and amino acid metabolism, activate genes for signal perception and transduction, and induce defense- and stress-responsive genes. Furthermore, analysis of Arabidopsis expression profiles suggests a redirection from growth to defense. After 3 weeks, severe disease symptoms can be detected for wild-type plants while mutants impaired in jasmonate synthesis and perception perform much better. Thus, plant jasmonates have an important influence on the interaction, which is already visible at the mRNA level before hormone changes occur. The plant and fungal genes that rapidly respond to the presence of the partner might be crucial for early recognition steps and the future development of the interaction. Thus they are potential targets for the control of V. dahliae-induced wilt diseases.Entities:
Keywords: Arabidopsis; JA; Verticillium dahliae; calcium; defense
Year: 2018 PMID: 29497409 PMCID: PMC5819561 DOI: 10.3389/fmicb.2018.00217
Source DB: PubMed Journal: Front Microbiol ISSN: 1664-302X Impact factor: 5.640
Figure 1GFP-labeled Verticillium dahliae colonizing roots of 10 day-old seedlings of Arabidopsis thaliana after 24 h co-culture. Shown are pictures (obtained from confocal microscopy) of the colonized Arabidopsis root surface (A–C), root tip (D–F), area around lateral roots (G–I) as well as a cross-section (J–L) and longitudinal section (M–O). A bright field image (left), the GFP image (middle), and the overlay of both (right) are shown for each analyzed area. Both the hyphae and the spores of V. dahliae show a GFP fluorescence.
Overview of differentially regulated genes in A. thaliana (ATH) and V. dahliae (VDA) co-culture compared to organisms grown separately.
| ATH grown with VDA vs. ATH alone | 903 | 240 |
| VDA grown with ATH vs. VDA alone | 1695 | 1594 |
KEGG pathway classification of genes differentially expressed in Arabidopsis alone vs. co-culture with V. dahliae.
| Metabolic pathways | 113 | 21.3 | ath01100 |
| Biosynthesis of secondary metabolites | 81 | 15.3 | ath01110 |
| Phenylpropanoid biosynthesis | 25 | 4.7 | ath00940 |
| Biosynthesis of amino acids | 20 | 3.8 | ath01230 |
| Plant-pathogen interaction | 18 | 3.4 | ath04626 |
| Glutathione metabolism | 17 | 3.2 | ath00480 |
| Phenylalanine. tyrosine and tryptophan biosynthesis | 13 | 2.4 | ath00400 |
| Amino sugar and nucleotide sugar metabolism | 11 | 2.1 | ath00520 |
| Photosynthesis | 10 | 1.9 | ath00195 |
| MAPK signaling pathway—plant | 10 | 1.9 | ath04016 |
| Plant hormone signal transduction | 9 | 1.7 | ath00380 |
| Photosynthesis—antenna proteins | 9 | 1.7 | ath04075 |
| Nitrogen metabolism | 8 | 1.5 | ath01200 |
| Carbon metabolism | 8 | 1.5 | ath00460 |
| Tryptophan metabolism | 8 | 1.5 | ath00910 |
| Cyanoamino acid metabolism | 7 | 1.3 | ath00966 |
| Starch and sucrose metabolism | 6 | 1.1 | ath00500 |
| Glucosinolate biosynthesis | 6 | 1.1 | ath00966 |
| Glycine. serine and threonine metabolism | 6 | 1.1 | ath00260 |
| Pentose and glucuronate interconversions | 5 | 0.9 | ath00040 |
| 2-Oxocarboxylic acid metabolism | 5 | 0.9 | ath01210 |
| Flavonoid biosynthesis | 5 | 0.9 | ath00941 |
| Glycolysis/Gluconeogenesis | 5 | 0.9 | ath00010 |
| Carotenoid biosynthesis | 5 | 0.9 | ath00906 |
| Cysteine and methionine metabolism | 5 | 0.9 | ath00270 |
| Protein processing in endoplasmic reticulum | 5 | 0.9 | ath04141 |
| Phenylalanine metabolism | 4 | 0.8 | ath00360 |
| Tropane. piperidine and pyridine alkaloid biosynthesis | 4 | 0.8 | ath00960 |
| Sulfur metabolism | 4 | 0.8 | ath00920 |
| Purine metabolism | 4 | 0.8 | ath00230 |
| Valine. leucine and isoleucine degradation | 4 | 0.8 | ath00280 |
| Sesquiterpenoid and triterpenoid biosynthesis | 4 | 0.8 | ath00909 |
| Beta-Alanine metabolism | 3 | 0.6 | ath00410 |
| SNARE interactions in vesicular transport | 3 | 0.6 | ath04130 |
| Fatty acid degradation | 3 | 0.6 | ath00071 |
| Fatty acid metabolism | 3 | 0.6 | ath01212 |
| Pentose phosphate pathway | 3 | 0.6 | ath00030 |
| Ubiquinone and other terpenoid-quinone biosynthesis | 3 | 0.6 | ath00130 |
| Propanoate metabolism | 3 | 0.6 | ath00640 |
| Pyruvate metabolism | 3 | 0.6 | ath00620 |
| Taurine and hypotaurine metabolism | 3 | 0.6 | ath00430 |
| Ascorbate and aldarate metabolism | 3 | 0.6 | ath00053 |
| Alpha-Linolenic acid metabolism | 3 | 0.6 | ath00592 |
| Fatty acid biosynthesis | 3 | 0.6 | ath00061 |
| Carbon fixation in photosynthetic organisms | 3 | 0.6 | ath00710 |
| Steroid biosynthesis | 3 | 0.6 | ath00100 |
| Galactose metabolism | 3 | 0.6 | ath00052 |
| Tyrosine metabolism | 3 | 0.6 | ath00350 |
| Inositol phosphate metabolism | 2 | 0.4 | ath00562 |
| Selenocompound metabolism | 2 | 0.4 | ath00450 |
| Monobactam biosynthesis | 2 | 0.4 | ath00261 |
| Isoquinoline alkaloid biosynthesis | 2 | 0.4 | ath00950 |
| Protein export | 2 | 0.4 | ath03060 |
| Linoleic acid metabolism | 2 | 0.4 | ath00591 |
| RNA degradation | 2 | 0.4 | ath03018 |
| Peroxisome | 2 | 0.4 | ath04146 |
| Fructose and mannose metabolism | 2 | 0.4 | ath00051 |
| Arachidonic acid metabolism | 1 | 0.2 | ath00590 |
| Citrate cycle (TCA cycle) | 1 | 0.2 | ath00020 |
| Alanine. aspartate and glutamate metabolism | 1 | 0.2 | ath00250 |
| Transporters | 1 | 0.2 | ath02010 |
| Riboflavin metabolism | 1 | 0.2 | ath00740 |
| Lysine degradation | 1 | 0.2 | ath00310 |
| Flavone and flavonol biosynthesis | 1 | 0.2 | ath00944 |
| Glyoxylate and dicarboxylate metabolism | 1 | 0.2 | ath00630 |
| Zeatin biosynthesis | 1 | 0.2 | ath00908 |
| Vitamin B6 metabolism | 1 | 0.2 | ath00750 |
| Valine. leucine and isoleucine biosynthesis | 1 | 0.2 | ath00290 |
| Terpenoid backbone biosynthesis | 1 | 0.2 | ath00900 |
| Biosynthesis of unsaturated fatty acids | 1 | 0.2 | ath01040 |
| Circadian rhythm—plant | 1 | 0.2 | ath04712 |
| Stilbenoid. diarylheptanoid and gingerol biosynthesis | 1 | 0.2 | ath00945 |
| Pantothenate and CoA biosynthesis | 1 | 0.2 | ath00770 |
| Butanoate metabolism | 1 | 0.2 | ath00650 |
| Indole alkaloid biosynthesis | 1 | 0.2 | ath00901 |
| Phagosome | 1 | 0.2 | ath04145 |
| Glycerophospholipid metabolism | 1 | 0.2 | ath00564 |
| Lysine biosynthesis | 1 | 0.2 | ath00310 |
Figure 2KEGG Mapper analysis of RNA-seq data for Arabidopsis-Verticillium co-culture. Shown are the mapped pathways (n = 3) for differentially expressed genes in Arabidopsis alone vs. co-culture (A) and Verticillium alone vs. co-culture (B). A full list of the other regulated pathways is shown in Tables 2, 3.
KEGG pathway classification of genes differentially expressed in Verticillium alone vs. co-culture.
| Metabolic pathways | 344 | 20.4 | vda01100 |
| Biosynthesis of secondary metabolites | 151 | 9.0 | vda01110 |
| Biosynthesis of antibiotics | 104 | 6.2 | vda01130 |
| Carbon metabolism | 55 | 3.3 | vda01200 |
| Ribosome | 50 | 3.0 | vda03010 |
| Biosynthesis of amino acids | 47 | 2.8 | vda01230 |
| Starch and sucrose metabolism | 35 | 2.1 | vda00500 |
| Glycolysis/Gluconeogenesis | 28 | 1.7 | vda00010 |
| Valine. leucine and isoleucine degradation | 26 | 1.5 | vda00280 |
| Pentose and glucuronate interconversions | 26 | 1.5 | vda00040 |
| Purine metabolism | 23 | 1.4 | vda00230 |
| Amino sugar and nucleotide sugar metabolism | 22 | 1.3 | vda00520 |
| Glycine. serine and threonine metabolism | 22 | 1.3 | vda00260 |
| Pyruvate metabolism | 22 | 1.3 | vda00620 |
| Oxidative phosphorylation | 22 | 1.3 | vda00190 |
| Tyrosine metabolism | 22 | 1.3 | vda00350 |
| Cysteine and methionine metabolism | 20 | 1.2 | vda00270 |
| Arginine and proline metabolism | 19 | 1.1 | vda00330 |
| Glycerolipid metabolism | 18 | 1.1 | vda00561 |
| Propanoate metabolism | 17 | 1.0 | vda00640 |
| Beta-Alanine metabolism | 17 | 1.0 | vda00410 |
| Tryptophan metabolism | 16 | 0.9 | vda00380 |
| Galactose metabolism | 16 | 0.9 | vda00052 |
| Peroxisome | 16 | 0.9 | vda04146 |
| Methane metabolism | 15 | 0.9 | vda00680 |
| Fructose and mannose metabolism | 15 | 0.9 | vda00051 |
| Butanoate metabolism | 15 | 0.9 | vda00650 |
| Cyanoamino acid metabolism | 15 | 0.9 | vda00460 |
| RNA transport | 14 | 0.8 | vda03013 |
| 2-Oxocarboxylic acid metabolism | 14 | 0.8 | vda01210 |
| Histidine metabolism | 13 | 0.8 | vda00340 |
| Protein processing in endoplasmic reticulum | 13 | 0.8 | vda04141 |
| Alanine. aspartate and glutamate metabolism | 13 | 0.8 | vda00250 |
| Ribosome biogenesis in eukaryotes | 12 | 0.7 | vda03008 |
| RNA degradation | 12 | 0.7 | vda03018 |
| Steroid biosynthesis | 12 | 0.7 | vda00100 |
| Phenylalanine metabolism | 12 | 0.7 | vda00360 |
| Lysine degradation | 12 | 0.7 | vda00310 |
| Pentose phosphate pathway | 12 | 0.7 | vda00030 |
| Fatty acid degradation | 11 | 0.7 | vda00071 |
| Glyoxylate and dicarboxylate metabolism | 11 | 0.7 | vda00630 |
| Glycerophospholipid metabolism | 11 | 0.7 | vda00564 |
| Sulfur metabolism | 11 | 0.7 | vda00920 |
| Pantothenate and CoA biosynthesis | 11 | 0.7 | vda00770 |
| Nicotinate and nicotinamide metabolism | 10 | 0.6 | vda00760 |
| Autophagy—yeast | 9 | 0.5 | vda04138 |
| Endocytosis | 9 | 0.5 | vda04144 |
| Fatty acid metabolism | 9 | 0.5 | vda01212 |
| Phenylalanine. tyrosine and tryptophan biosynthesis | 8 | 0.5 | vda00400 |
| Ubiquinone and other terpenoid-quinone biosynthesis | 8 | 0.5 | vda00130 |
| Valine. leucine and isoleucine biosynthesis | 8 | 0.5 | vda00290 |
| Porphyrin and chlorophyll metabolism | 8 | 0.5 | vda00860 |
| Spliceosome | 8 | 0.5 | vda03040 |
| Pyrimidine metabolism | 7 | 0.4 | vda00240 |
| Arginine biosynthesis | 7 | 0.4 | vda00220 |
| Nitrogen metabolism | 7 | 0.4 | vda00910 |
| Aminoacyl-tRNA biosynthesis | 7 | 0.4 | vda00970 |
| Glutathione metabolism | 6 | 0.4 | vda00480 |
| Folate biosynthesis | 6 | 0.4 | vda00790 |
| Ubiquitin mediated proteolysis | 6 | 0.4 | vda04120 |
| Terpenoid backbone biosynthesis | 6 | 0.4 | vda00900 |
| Nucleotide excision repair | 6 | 0.4 | vda03420 |
| Citrate cycle (TCA cycle) | 6 | 0.4 | vda00020 |
| Other glycan degradation | 5 | 0.3 | vda00511 |
| Mitophagy—yeast | 5 | 0.3 | vda04139 |
| Base excision repair | 5 | 0.3 | vda03410 |
| Taurine and hypotaurine metabolism | 5 | 0.3 | vda00430 |
| Proteasome | 5 | 0.3 | vda03050 |
| Sphingolipid metabolism | 5 | 0.3 | vda00600 |
| MAPK signaling pathway—yeast | 5 | 0.3 | vda04011 |
| Various types of N-glycan biosynthesis | 5 | 0.3 | vda00513 |
| Phagosome | 5 | 0.3 | vda04145 |
| Ascorbate and aldarate metabolism | 5 | 0.3 | vda00053 |
| Fatty acid elongation | 4 | 0.2 | vda00062 |
| Riboflavin metabolism | 4 | 0.2 | vda00740 |
| SNARE interactions in vesicular transport | 4 | 0.2 | vda04130 |
| N-Glycan biosynthesis | 4 | 0.2 | vda00510 |
| One carbon pool by folate | 4 | 0.2 | vda00670 |
| Vitamin B6 metabolism | 4 | 0.2 | vda00750 |
| mRNA surveillance pathway | 4 | 0.2 | vda03015 |
| Carotenoid biosynthesis | 4 | 0.2 | vda00906 |
| Linoleic acid metabolism | 3 | 0.2 | vda00591 |
| Ether lipid metabolism | 3 | 0.2 | vda00565 |
| Meiosis—yeast | 3 | 0.2 | vda04113 |
| Synthesis and degradation of ketone bodies | 3 | 0.2 | vda00072 |
| Cell cycle—yeast | 3 | 0.2 | vda04111 |
| Glycosylphosphatidylinositol (GPI)-anchor biosynthesis | 3 | 0.2 | vda00563 |
| Arachidonic acid metabolism | 3 | 0.2 | vda00590 |
| Sulfur relay system | 3 | 0.2 | vda04122 |
| Basal transcription factors | 3 | 0.2 | vda03022 |
| Thiamine metabolism | 3 | 0.2 | vda00730 |
| Selenocompound metabolism | 3 | 0.2 | vda00450 |
| Glycosphingolipid biosynthesis—globo and isoglobo series | 3 | 0.2 | vda00603 |
| Phosphonate and phosphinate metabolism | 2 | 0.1 | vda00440 |
| Non-homologous end-joining | 2 | 0.1 | vda03450 |
| RNA polymerase | 2 | 0.1 | vda03020 |
| Autophagy—other | 2 | 0.1 | vda04136 |
| Biosynthesis of unsaturated fatty acids | 2 | 0.1 | vda01040 |
| Alpha-Linolenic acid metabolism | 2 | 0.1 | vda00592 |
| Lysine biosynthesis | 2 | 0.1 | vda00300 |
| DNA replication | 2 | 0.1 | vda03030 |
| Protein export | 2 | 0.1 | vda03060 |
| Inositol phosphate metabolism | 2 | 0.1 | vda00562 |
| Biotin metabolism | 2 | 0.1 | vda00780 |
| Mismatch repair | 2 | 0.1 | vda03430 |
| Mannose type O-glycan biosynthesis | 1 | 0.1 | vda00515 |
| Lipoic acid metabolism | 1 | 0.1 | vda00785 |
| Other types of O-glycan biosynthesis | 1 | 0.1 | vda00514 |
| Phosphatidylinositol signaling system | 1 | 0.1 | vda04070 |
| Monobactam biosynthesis | 1 | 0.1 | vda00261 |
| Fatty acid biosynthesis | 1 | 0.1 | vda00061 |
| Sesquiterpenoid and triterpenoid biosynthesis | 1 | 0.1 | vda00909 |
| Caffeine metabolism | 1 | 0.1 | vda00232 |
| AGE-RAGE signaling pathway in diabetic complications | 1 | 0.1 | vda04933 |
| Carbapenem biosynthesis | 1 | 0.1 | vda00332 |
| ABC transporters | 1 | 0.1 | vda02010 |
| Glycosaminoglycan degradation | 1 | 0.1 | vda00531 |
Figure 3Phenotype of V. dahliae (VD)-infected Arabidopsis WT and JA mutant plants. Shown are representative phenotypes of WT, jar1, coi1-16, and cyp94B3 plants 10 (upper two rows) and 20 dpi (lower two rows) grown in Magenta boxes. 14 day-old plants were treated with water (control, n = 6) or VD (n = 9) for 24 h and then transferred to the boxes.
Figure 4Chlorophyll fluorescence (QY_max) analysis of Arabidopsis WT and JA mutant plants after 24 h of V. dahliae infection. Shown are the QY_max values [± SE, n = 6 (control) and 9 (VD-infected)] in control (plain color) and VD-infected (stripes) plants 10 and 20 dpi. QY_max was analyzed in WT (white), jar1 (light gray), coi1-16 (dark gray) and cyp94B3 (black) plants. Statistically significant differences between controls and between infected plants were analyzed by one-way ANOVA separately, p < 0.05 (Sidak). Different letters indicate a statistically significant difference.
Figure 5Colonization of Arabidopsis WT and JA mutant plants by V. dahliae after 24 h. Shown is the normalized fold expression (± SE, n = 3) of VD_Actin2 in VD-infected WT, jar1, coi1-16 and cyp94B3 plants (A) and the relative expression in % (B). The expression level of VD_Actin2 in VD-infected WT plants was used as control and set to 1.0. The mRNA levels for each cDNA probe were normalized with respect to the RPS18B mRNA level. Statistically significant differences between the mutants were analyzed by one-way ANOVA, p < 0.05 (Sidak). Different letters indicate a statistically significant difference.
Figure 6Phytohormone levels in Arabidopsis WT and JA mutant plants after 24 h of V. dahliae infection. Shown is the content (± SE, n = 10) of SA (A), JA (B), and JA-Ile (C) in control (white) and VD-infected (black) WT, jar1, coi1-16, and cyp94B3 plants. Statistically significant differences were analyzed by Mann Whitney U-test, p < 0.05; n.s. not significant, **p < 0.01.
Figure 7Expression of selected genes in Arabidopsis WT and JA mutant plants after 24 h of V. dahliae infection. Shown is the normalized fold expression (± SE, n = 3) of WAKL10 (A), SWEET11 (B), and SWEET3 (C) in VD-infected WT, jar1, coi1-16, and cyp94B3 plants. The expression level of genes of interest (GOIs) in water-treated plants was used as control and set to 1.0. The mRNA levels for each cDNA probe were normalized with respect to the RPS18B mRNA level. Statistically significant differences between the mutants were analyzed by one-way ANOVA, p < 0.05 (Sidak). Different letters indicate a statistically significant difference.
Figure 8Expression of selected genes in V. dahliae after colonizing Arabidopsis WT and JA mutant plants for 24 h. Shown is the normalized fold expression (± SE, n = 3) of VDAG_02979 (A) and VDAG_06565 (PARN) (B) in VD-colonized WT, jar1, coi1-16, and cyp94B3 plants. The expression level of GOIs in VD alone was used as control and set to 1.0. The mRNA levels for each cDNA probe were normalized with respect to the VD_Actin2 mRNA level. Statistically significant differences between the mutants were analyzed by one-way ANOVA, p < 0.05 (Sidak). Different letters indicate a statistically significant difference.